To provide a brief background, the TRAILBLAZER-ALZ 2 LTE study was a Phase 3, double-blind extension of the original ...

Boston: Superluminal Medicines, a drug discovery company integrating AI/ML, protein dynamics, and structural biology to ...

In 2035, college graduates may explore the solar system in highly-paid, exciting roles, while AI changes the job market. Tech ...

The Global Women’s Health Market is expected to witness a growth rate of 4-5% in the next five years. Growing incidence of ...

Oral GLP-1 drugs will fill a niche rather than displace injections, according to analysts. TD Cowen estimates that pills will ...

Tonmya – a new under-the-tongue formulation of well-established muscle relaxant cyclobenzaprine HCl – has been cleared to ...

Former Uber regional manager and Oscar Health COO has set out on her own to help busy people get help with their schedules by ...

Investors bought in after the company got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug ...

Novo Nordisk's GLP-1 drugs have been under considerable competitive pressure in the last few months, so the company will be ...

Eli Lilly and Company witnessed a notable insider buy recently. David Ricks, the Chairman, invested a hefty $1.1 million in ...

Columbia Threadneedle’s Contrarian Core Fund beat its benchmark in Q2 2025 amid AI-fueled tech gains. Explore what drove ...